Intellia Therapeutics Inc sell StockNews.com
Start price
11.05.24
/
50%
€22.51
Target price
11.05.25
-
Performance (%)
-67.08%
End price
12.05.25
€7.41
Summary
This prediction ended on 12.05.25 with a price of €7.41. The SELL prediction by StockNews_com for Intellia Therapeutics Inc performed very well with a performance of -67.08%. StockNews_com has a follow-up prediction for Intellia Therapeutics Inc where he still thinks Intellia Therapeutics Inc is a Sell. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Intellia Therapeutics Inc | -5.055% | -5.055% | 32.370% |
| iShares Core DAX® | -2,53 % | -5,19 % | 4,91 % |
| iShares Nasdaq 100 | -0,03 % | 1,56 % | 21,79 % |
| iShares Nikkei 225® | -4,20 % | -7,55 % | 31,13 % |
| iShares S&P 500 | -0,80 % | 0,16 % | 15,78 % |
Comments by StockNews_com for this prediction
In the thread Intellia Therapeutics Inc diskutieren
Intellia Therapeutics, Inc. (NASDAQ: NTLA) was upgraded by analysts at StockNews.com to a "sell" rating.
Ratings data for NTLA provided by MarketBeat
In the thread Trading Intellia Therapeutics Inc
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten
Current prediction by StockNews_com for Intellia Therapeutics Inc
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€9.06
08.11.25
08.11.25
-
08.11.26
08.11.26
24.45%
11.03.26
11.03.26
Stopped prediction by StockNews_com for Intellia Therapeutics Inc
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€10.60
18.01.26
18.01.26
-
18.01.27
18.01.27
6.32%
11.03.26
11.03.26
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€7.90
27.12.25
27.12.25
-
27.12.26
27.12.26
42.62%
11.03.26
11.03.26
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€7.77
30.11.25
30.11.25
-
30.11.26
30.11.26
45.08%
11.03.26
11.03.26
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€15.77
09.11.24
09.11.24
-
09.11.25
09.11.25
-42.57%
10.11.25
10.11.25